Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haesook T Kim

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Cumulative incidence in competing risks data and competing risks regression analysisHaesook T Kim
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedomHaesook T Kim, Philippe Armand
Transplantation and Cellular Therapy|May 18, 2021
Novel Composite Endpoints after Allogeneic Hematopoietic Cell TransplantationHaesook T Kim, Brent Logan, Daniel J Weisdorf
JAMA Oncology|May 15, 2025
Challenges in Shared Care Research in Hematopoietic Cell Transplantation-ReplyGregory A Abel, Haesook T Kim, Robert J Soiffer
Journal of Clinical Medicine|March 14, 2026
Clinicopathological Characteristics and Survival Outcomes of Gastrointestinal Neuroendocrine Tumors in a Large Safety Net HospitalRamya Singhal, Grace H Kim, Isa Jacoba, et al.
Bone Marrow Transplantation|August 22, 2022
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphomaEric D Jacobsen, Haesook T Kim, Erin Jeter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
Complementary medicine use among women enrolled in a genetic testing programLisa M DiGianni, Haesook T Kim, Karen Emmons, et al.
Frontiers in Immunology|October 3, 2022
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host diseaseVeronica Donato, Haesook T Kim, Peter Stowe, et al.
Leukemia & Lymphoma|November 23, 2017
Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometryAndrew Aw, Haesook T Kim, Stacey M Fernandes, et al.
The American Journal of Gastroenterology|February 12, 2024
A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net HospitalSofia D Shaikh, Isa Jacoba, Natalie Sun, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Cumulative incidence in competing risks data and competing risks regression analysisHaesook T Kim
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedomHaesook T Kim, Philippe Armand
Transplantation and Cellular Therapy|May 18, 2021
Novel Composite Endpoints after Allogeneic Hematopoietic Cell TransplantationHaesook T Kim, Brent Logan, Daniel J Weisdorf
JAMA Oncology|May 15, 2025
Challenges in Shared Care Research in Hematopoietic Cell Transplantation-ReplyGregory A Abel, Haesook T Kim, Robert J Soiffer
Journal of Clinical Medicine|March 14, 2026
Clinicopathological Characteristics and Survival Outcomes of Gastrointestinal Neuroendocrine Tumors in a Large Safety Net HospitalRamya Singhal, Grace H Kim, Isa Jacoba, et al.
Bone Marrow Transplantation|August 22, 2022
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphomaEric D Jacobsen, Haesook T Kim, Erin Jeter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
Complementary medicine use among women enrolled in a genetic testing programLisa M DiGianni, Haesook T Kim, Karen Emmons, et al.
Frontiers in Immunology|October 3, 2022
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host diseaseVeronica Donato, Haesook T Kim, Peter Stowe, et al.
Leukemia & Lymphoma|November 23, 2017
Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometryAndrew Aw, Haesook T Kim, Stacey M Fernandes, et al.
The American Journal of Gastroenterology|February 12, 2024
A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net HospitalSofia D Shaikh, Isa Jacoba, Natalie Sun, et al.
Pageof 20